Omnicell (OMCL) Cash & Equivalents (2010 - 2026)

Omnicell (OMCL) has 17 years of Cash & Equivalents data on file, last reported at $174.9 million in Q1 2026.

• Quarterly Cash & Equivalents fell 54.79% year-over-year to $174.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.9 million (down 54.79% YoY) and the FY2025 annual result came in at $196.5 million, down 46.77% from the prior year.
• Cash & Equivalents fell to $174.9 million in Q1 2026 per OMCL's latest filing, from $196.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $570.6 million in Q3 2024 and bottomed at $174.9 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $369.2 million (2024), against an average of $359.3 million.
• The widest annual swing landed in 2023, when Cash & Equivalents jumped 67.73%; it then tumbled 68.44% in 2025.
• Tracing OMCL's Cash & Equivalents over 5 years: stood at $330.4 million in 2022, then surged by 41.65% to $468.0 million in 2023, then slipped by 21.11% to $369.2 million in 2024, then sank by 46.77% to $196.5 million in 2025, then dropped by 11.0% to $174.9 million in 2026.
• Per Business Quant, the three latest OMCL Cash & Equivalents figures stand at $174.9 million (Q1 2026), $196.5 million (Q4 2025), and $180.1 million (Q3 2025).

Peer Comparison